David Nakasone
Head of Investor Relations
Replay available
Tarsus Pharmaceuticals, Inc. (TARS) Q4 2025 Earnings Call
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Q4 2025 earnings conference call, held 2026-02-23. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bobby Azamian
Chief Executive Officer and Chairman
Aziz Matawala
Chief Commercial Officer
Stacia Nirvanan
Chief Operating Officer
Jeff Farah
Chief Financial Officer and Chief Strategy Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tarsus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.980 Good afternoon, and welcome to TARSA's fourth quarter and full year 2025 financial results 00:00:04.980 -- 00:00:10.170 conference call. As a reminder, this call is being recorded, and all participants 00:00:10.170 -- 00:00:12.353 are in a listen-only mode. 00:00:12.353 -- 00:00:15.259 After the speaker's presentation, there will be a question and answer session. 00:00:15.259 -- 00:00:19.567 At this time, I would like to turn the call over to David Nakasone, Head of Investor 00:00:19.567 -- 00:00:24.171 Relations, to lead off the call. David, you may begin. 00:00:24.685 -- 00:00:28.551 Thank you. Before we begin, I encourage everyone to visit the investor section of the 00:00:28.551 -- 00:00:32.638 TARCIS website to see the earnings release and related materials we will be discussing 00:00:32.638 -- 00:00:37.486 today. Joining me on the call this afternoon are Bobby Azamian, our Chief Executive Officer 00:00:37.486 -- 00:00:42.194 and Chairman, Aziz Matawala, our Chief Commercial Officer, Stacia Nirvanan, our Chief 00:00:42.194 -- 00:00:47.563 Operating Officer, and Jeff Farah, our Chief Financial Officer and Chief Strategy Officer. 00:00:47.563 -- 00:00:52.023 I'd like to draw your attention to slide three, which contains our forward-looking statements 00:00:52.023 -- 00:00:55.648 During this call, we will be making forward-looking statements that are based on our 00:00:55.648 -- 00:01:01.296 current expectations and beliefs. These statements are subject to certain risks and uncertainties, 00:01:01.296 -- 00:01:03.840 and our actual results may differ materially. 00:01:03.840 -- 00:01:07.925 I encourage you to consult the risk factors contained in our SEC filings for additional 00:01:07.925 -- 00:01:12.071 details. With that, I'll...